venBio Partners LLC

CIK 0001776382 · Q2 2026

13F Equity AUM

$519.4M

+85.1% QoQ

Positions

+1 QoQ

AUM Rank

#4,822

Top 38%

Skill Alpha (FF)

+8.6%/yr^ns

No Clear Edge

Rank #436 · Top 5%

vs S&P -20.2%/yr (unadj.)

Quarters Tracked

~7 years

Portfolio Concentration

Top 5: 95.8%Top 10: 100.0%Top 20: 100.0%

PHVS30.9%

PARABILIS MEDICINES INC27.8%

ALMS24.5%

SP4P7.4%

ALXO5.1%

HRMY3.3%

LYEL0.9%

HHI (Herfindahl-Hirschman Index) measures portfolio concentration. Low (<1500) = diversified, Moderate (1500-2500), High (>2500) = concentrated bets.

Sector Allocation

Healthcare72.3%

Unclassified27.8%

Portfolio weight by GICS sector based on latest 13F filing. Sectors below 2% are grouped as “Other.”

Position Sizing

Positions: 7Median: 7.44%Avg: 14.29%

0–0.5%

0(0.0%)

0.5–1%

1(0.9%)

1–3%

0(0.0%)

3–5%

1(3.3%)

5%+

5(95.8%)

Count of positions per weight bucket — (%) = combined portfolio weight

Loading summary cards...

Portfolio Overlap

Shared: 0Unique: 7vs 20 funds

0%Low

Fund positions

Consensus CUSIPs

Jaccard similarity of this fund’s portfolio vs the consensus of top 20 funds by AUM. Low (<15%) = contrarian, Moderate (15-40%), High (>40%) = follows the crowd.

Loading overlap analysis...

Position Changes This Quarter

New2Increased1Decreased1Exited1

New Positions

PARABILIS MEDICINES …27.8%

+5.3M

SP4P7.4%

+5.9M

Increased

PHVS30.9%

+4K(+0%)

Decreased

HRMY3.3%

-17,000(-3%)

Exited

ARTV

-531,337

Quarter-over-quarter changes compared to prior 13F filing. New = first appearance; Exited = no longer held.

Loading position changes...

Holdings

Loading holdings...